75 results
8-K
EX-99.1
ZOM
Zomedica Corp
15 Mar 24
Zomedica Provides Corporate NYSE American Listing Update
7:46am
pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors
DEFA14A
ZOM
Zomedica Corp
6 Feb 24
Additional proxy soliciting materials
5:14pm
products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations
DEFA14A
ZOM
Zomedica Corp
31 Jan 24
Additional proxy soliciting materials
8:00am
to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other
DEFA14A
ZOM
Zomedica Corp
26 Jan 24
Additional proxy soliciting materials
12:00am
, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our
DEFA14A
b9150ur
17 Jan 24
Additional proxy soliciting materials
4:01pm
8-K
EX-99.1
73j0gzxesy8 n518
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
yx9a5w
13 Sep 23
Zomedica Provides Corporate Update
5:58pm
8-K
EX-99.1
ql307j8q 2aswtgu0w
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-99.1
n6bv75lvk r9vh
11 May 23
Results of Operations and Financial Condition
4:27pm
8-K
EX-99.1
g1pp9hi1
9 May 23
Other Events
8:57am
8-K
EX-99.1
vuk6bsl7qzlw77s6ub
14 Nov 22
Results of Operations and Financial Condition
4:24pm
8-K
EX-99.1
nvbp 8redspp1
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
EX-99.1
16s6 v7i5j6lilnqr26
15 Aug 22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
6:12pm